Procalcitonin and other biomarkers in COVID-19
[2020-07-01]
Procalcitonin in Emergency Department Patients With Suspected COVID-19
      
      
      
Procalcitonin in Emergency Department Patients With Suspected COVID-19
Presentation  by Dr. Charles Cairns
On using biomarkers (classifiers) to distinguish between causes of acute inflammation (infectious vs non infectious, bacterial vs viral, co-infections) with emphasis on procalcitonin. Procalcitonin is elevated in severe covid, but not in non-severe (95% of cases) 
16:54 procalcitonin (PCT) is a prohormone of calcitonin ; elevated PCT levels indicate bacterial infection accompanied by systemic inflammatory reaction 
25:09 another really nice diagram
{ seems to indicate that antibody dependent enhancement can occur in the course of a single infection, rather than during a re-infection } 
29:11 laboratory parameters in covid-19 patients
33:10 angiogenesis in in lungs from covid-19 or flu (H1N1)
D-dimer may be laboratory correlate of angiogenesis; { probably more directly correlated to hypoxia inducible factor, but I guess d-dimer is something more routinely measured } 
35:55 review of PCT in covid-19 
37:13 summary of presentation 
"we need to understand the role of bacterial super infection in patients" 
Comments
Post a Comment